Fangfang
Cheng
ab,
Yiting
Gao
b,
Beibei
Ren
c,
Zhongyang
Zhang
b,
Minghui
Dong
b,
Guoxiang
Sun
d,
Chaohui
Song
ab,
Siqi
Wang
d,
Haixia
Gao
*b,
Chunhua
Zhou
*a and
Lingjiao
Wang
*a
aDepartment of Clinical Pharmacy, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. E-mail: wlj@hebmu.edu.cn; zhouchunhua80@126.com
bDepartment of Pharmacology, Center for Innovative Drug Research and Evaluation, Institute of Medical Science and Health, The Hebei Collaboration Innovation Center for Mechanism, Diagnosis and Treatment of Neurological and Psychiatric Disease, The Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Medical University, Hebei, China. E-mail: gaohx686@hebmu.edu.cn
cHebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China
dSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China
First published on 5th December 2024
Correction for ‘A rapid evaluation method for the quality consistency assessment and spectrum–effect relationship study of Xiaohuoluo Pills developed based on combined spectral and chromatography technology’ by Fangfang Cheng et al., Anal. Methods, 2024, https://doi.org/10.1039/D4AY01029A.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2025 |